Bevacizumab for front-Line Treatment of Epithelial Ovarian, Fallopian tube or Primary Peritoneal Cancer Patients With High Risk of Relapse: a Cost Effective option for Canadian Patients

P. Ghatage; E.J. Wright; I. Martin Nunez; L. Yin; J. Ray

doi:10.1016/j.jval.2015.03.1168

Bevacizumab for front-Line Treatment of Epithelial Ovarian, Fallopian tube or Primary Peritoneal Cancer Patients With High Risk of Relapse: a Cost Effective option for Canadian Patients

Value in Health ◽

10.1016/j.jval.2015.03.1168 ◽

2015 ◽

Vol 18 (3) ◽

pp. A202 ◽

Cited By ~ 1

Author(s):

P. Ghatage ◽

E.J. Wright ◽

I. Martin Nunez ◽

L. Yin ◽

J. Ray

Keyword(s):

High Risk ◽

Cancer Patients ◽

Fallopian Tube ◽

Cost Effective ◽

Line Treatment ◽

Front Line ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Effective Option ◽

Risk Of Relapse

Download Full-text

Disparities between Uptake of Germline BRCA1/2 Gene Tests and Implementation of Post-test Management Strategies in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Journal of Korean Medical Science ◽

10.3346/jkms.2021.36.e241 ◽

2021 ◽

Vol 36 (38) ◽

Author(s):

Young Min Hur ◽

Jaehee Mun ◽

Mi-Kyung Kim ◽

Maria Lee ◽

Yun Hwan Kim ◽

...

Keyword(s):

Cancer Patients ◽

Fallopian Tube ◽

Management Strategies ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Test Management ◽

Post Test

Download Full-text

Toxicity profile of olaparib maintenance monotherapy for Japanese platinum-sensitive relapsed ovarian, fallopian tube and primary peritoneal cancer patients

10.3802/jgo.2021.32.s1.o21 ◽

2021 ◽

Author(s):

Tomoko Yoshihama ◽

Tatsuyuki Chiyoda ◽

Yuka Kuroda ◽

Yusuke Kobayashi ◽

Wataru Yamagami ◽

...

Keyword(s):

Cancer Patients ◽

Fallopian Tube ◽

Toxicity Profile ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Platinum Sensitive

Download Full-text

EP988 Hematologic markers of survival outcome in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy

10.1136/ijgc-2019-esgo.1034 ◽

2019 ◽

Author(s):

P Suprasert ◽

D Jeerakornpassawat

Keyword(s):

Cancer Patients ◽

Fallopian Tube ◽

Survival Outcome ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Platinum Based Chemotherapy

Download Full-text

365 Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy for advanced ovarian, fallopian tube and primary peritoneal cancer patients

10.1136/ijgc-2020-igcs.315 ◽

2020 ◽

Author(s):

H Nomura ◽

N Iwasa ◽

F Kataoka ◽

T Chiyoda ◽

W Yamagami ◽

...

Keyword(s):

Cancer Patients ◽

Fallopian Tube ◽

Feasibility Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Dose Dense

Download Full-text

Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients

International Journal of Clinical Oncology ◽

10.1007/s10147-021-02050-3 ◽

2021 ◽

Author(s):

Naomi Iwasa-Inoue ◽

Hiroyuki Nomura ◽

Fumio Kataoka ◽

Tatsuyuki Chiyoda ◽

Tomoko Yoshihama ◽

...

Keyword(s):

Cancer Patients ◽

Fallopian Tube ◽

Feasibility Study ◽

Debulking Surgery ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Interval Debulking Surgery ◽

Dose Dense

Download Full-text

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy

Obstetrics & Gynecology Science ◽

10.5468/ogs.2020.63.1.55 ◽

2020 ◽

Vol 63 (1) ◽

pp. 55

Author(s):

Dhammapoj Jeerakornpassawat ◽

Prapaporn Suprasert

Keyword(s):

Cancer Patients ◽

Fallopian Tube ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Chemotherapeutic Response ◽

Platinum Based Chemotherapy

Download Full-text

Phase I study of intraperitoneal IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer administered in combination with pegylated liposomal doxorubicin in recurrent or persistent epithelial ovarian, Fallopian tube, or primary peritoneal cancer patients: An NRG/GOG study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.5541 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5541-5541 ◽

Cited By ~ 5

Author(s):

Premal H. Thaker ◽

William E Brady ◽

William Hampton Bradley ◽

Khursheed Anwer ◽

Ronald David Alvarez

Keyword(s):

Phase I ◽

Cancer Patients ◽

Fallopian Tube ◽

Phase I Study ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

816TiP Randomized phase III trial on niraparib - TSR-042 (dostarlimab) vs physician’s choice CHEmotherapy in recurrent ovarian, fallopian tube or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1258 ◽

2021 ◽

Vol 32 ◽

pp. S768-S769

Author(s):

D. Lorusso ◽

L. Musacchio ◽

S. Pignata ◽

E.I. Braicu ◽

D. Cibula ◽

...

Keyword(s):

Cancer Patients ◽

Fallopian Tube ◽

Phase Iii ◽

Phase Iii Trial ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Improved Optimal Cytoreduction Rates for Stages IIIC and IV Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer: A Change in Surgical Approach

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70606-4 ◽

2006 ◽

Vol 2006 ◽

pp. 466-467

Author(s):

G. Rodriguez

Keyword(s):

Fallopian Tube ◽

Surgical Approach ◽

Optimal Cytoreduction ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

PREDICTING OUTCOME IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER ACCORDING TO HISTOLOGICAL TUMOUR RESPONSE TO NEO-ADJUVANT CHEMOTHERAPY, AT THE TIME OF INTERVAL DEBULKING.

10.26226/morressier.5770e29cd462b80290b4c049 ◽

2016 ◽

Author(s):

Sinead Barry

Keyword(s):

Adjuvant Chemotherapy ◽

Fallopian Tube ◽

Tumour Response ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Predicting Outcome ◽

Neo Adjuvant Chemotherapy

Download Full-text